Search results
Results from the WOW.Com Content Network
The name was changed again in 1965 to the Pharmaceutical Manufacturers Association of Canada (PMAC), and to Canada’s Research-Based Pharmaceutical Companies (Rx&D) in 1999. [7] Finally, in 2016, the name Innovative Medicines Canada was introduced.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
The pharmaceutical industry in Canada employs approximately 30,000 people. It supplies about one third of the domestic pharmaceutical consumer market of $27 billion annually. [1] This accounts for ~16% of yearly health expenditures. Canada had a pharmaceutical trade deficit of $8.5 billion in 2018 with exports of $11 billion and imports of $19. ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Pages in category "Pharmaceutical companies of Canada" The following 24 pages are in this category, out of 24 total. This list may not reflect recent changes. A.
Pharmascience Inc. is a Quebec-based pharmaceutical company founded by pharmacists Morris Goodman and Ted Wise in 1983. Pharmascience Inc. is headquartered in Montreal and distributes its products to more than 50 countries. [2] [3]
Apotex Inc. is a Canadian pharmaceutical corporation. [4] Founded in 1974 by Barry Sherman, the company is the largest producer of generic drugs in Canada, with annual sales exceeding CA$2.5 billion. [5]
Acuitas Therapeutics Inc. is a Canadian biotechnology company based in Vancouver, British Columbia. The company was established in February 2009 to specialize in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticle (LNP) technology, a key component of the mRNA vaccines deployed for COVID-19. [1] [2]